- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-01-0166411

Unimedia Pharmaceuticals Private Limited
About Unimedia Pharmaceuticals Private Limited
Data last updated:
Unimedia Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 March 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24233GJ2013PTC074110. Its GSTIN is 24AALCA6412E1Z1 (Gujarat).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It was formerly known as Aqsa Remedies Private Limited. It is led by directors Mohammadzahid Abdulrashid Mall and Abdulrashid Abdulmajid Mall.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot 1706 Phase III GIDC Vatva, Ahmedabad, Gujarat, India – 382445.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.73 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹19,355 (net margin 0.1%) and EBITDA of ₹8.55 Lakh (EBITDA margin 4.9%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 5% over five years.
As per MCA filings, the company has open charges of ₹60.6 Lakh on record.
Unimedia Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0166411). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Unimedia Pharmaceuticals
Contact details
Unimedia Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot 1706 Phase III GIDC Vatva, Ahmedabad, Gujarat, India – 382445
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Unimedia Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Unimedia Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Unimedia Pharmaceuticals Private Limited, buy the company report.
Financials of Unimedia Pharmaceuticals Private Limited
FY 2025 filings availableUnimedia Pharmaceuticals Private Limited reported revenue of ₹1.73 Cr (up 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 15% growth in the latest year. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.55 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹19,355 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.9% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Unimedia Pharmaceuticals Private Limited, buy the company report.
Board of directors of Unimedia Pharmaceuticals Private Limited
Unimedia Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammadzahid Abdulrashid Mall | Director | 21 Mar 2013 | 13 Years 8 Months | Current |
| Abdulrashid Abdulmajid Mall | Director | 21 Mar 2013 | 13 Years 8 Months | Current |
Auditor
Unimedia Pharmaceuticals Private Limited is audited by LAKHANI ISMAILI TUNDIYA & CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| LAKHANI ISMAILI TUNDIYA & CO. | FY 2024 | 119573W |
Shareholding
The shareholding of Unimedia Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Unimedia Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Nov 2023 | 100836944 | Others | ₹9.33 Lakh | Open | |
| 15 Nov 2019 | 100320020 | Others | ₹9 Lakh | Open | |
| 18 Nov 2013 | 10466940 | Others | ₹42.27 Lakh | Open |
To see the full charge records of Unimedia Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Unimedia Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unimedia Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Unimedia Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AALCA6412E1Z1 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Unimedia Pharmaceuticals Private Limited, buy the company report.
Recent activity
Unimedia Pharmaceuticals Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Abdulrashid Abdulmajid Mall was appointed as Director on 21 Mar 2013.
Frequently asked questions
Unimedia Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 March 2013 (13+ years old) and is registered under CIN U24233GJ2013PTC074110.
Unimedia Pharmaceuticals has 2 current directors:
- Mohammadzahid Abdulrashid Mall - Director
- Abdulrashid Abdulmajid Mall - Director
The latest financial statements of Unimedia Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Unimedia Pharmaceuticals is 24AALCA6412E1Z1, registered in Gujarat.
The CIN (Corporate Identification Number) of Unimedia Pharmaceuticals is U24233GJ2013PTC074110. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unimedia Pharmaceuticals was incorporated on 21 March 2013, making it 13+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Abdulrashid Abdulmajid Mall was appointed as Director on 21 Mar 2013. Mohammadzahid Abdulrashid Mall was appointed as Director on 21 Mar 2013.
Yes, Unimedia Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0166411).
The registered office of Unimedia Pharmaceuticals is at Plot 1706 Phase III GIDC Vatva, Ahmedabad, Gujarat, India – 382445.
Unimedia Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

